Autolus Therapeutics PLC (NASDAQ:AUTL)
| 2.51 BATS BZX Real-Time Price As of 11:51am ET |  +0.1499 / +6.35%Today’s Change | 1.60 Today|||52-Week Range 3.54 | +32.11% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 1 2019 | -- | -- | -- | |||
| Revenue and Income | Net Revenues | 0.00 | -- | -- | -- | -- |
| Operating Expenses | Gross Income | 0.00 | -- | -- | -- | -- |
| General Expenses | 32.5M | -- | -- | -- | ||
| Research And Development | 22.8M | -- | -- | -- | ||
| Total Operating Expenses | 32.5M | -- | -- | -- | ||
| Non-Operating Expenses | Operating Income | -32.5M | -- | -- | -- | |
| Other Expenses | 990.4K | -- | -- | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -30.9M | -- | -- | -- | |
| Income Taxes | -3.5M | -- | -- | -- | ||
| Net Income | -27.5M | -- | -- | -- | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 39.5M | -- | -- | -- | |
| Shares To Calculate EPS Diluted | 39.5M | -- | -- | -- | ||
| Earnings Per Share | EPS | -$0.70 | -- | -- | -- | |
| EPS Diluted | -$0.70 | -- | -- | -- | ||
